S R Wiegell
Overview
Explore the profile of S R Wiegell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hendel K, Jemec G, Haedersdal M, Wiegell S
J Eur Acad Dermatol Venereol
. 2021 Jul;
35(11):2208-2215.
PMID: 34219303
Basal cell carcinoma (BCC) is the most common type of cancer and an increasing incidence stimulates the interest in new treatments such as electrochemotherapy (ECT) with bleomycin. This systematic review...
2.
Wulf H, Wiegell S
J Eur Acad Dermatol Venereol
. 2020 Sep;
35(3):e230-e232.
PMID: 32977367
No abstract available.
3.
Nissen C, Heerfordt I, Wiegell S, Mikkelsen C, Wulf H
Br J Dermatol
. 2016 Oct;
176(5):1241-1246.
PMID: 27696393
Background: Photodynamic therapy (PDT) with methyl aminolaevulinate (MAL) is highly effective for treating actinic keratosis (AK) on the face/scalp, but less effective on the extremities. Insufficient accumulation of protoporphyrin IX...
4.
Wiegell S, Petersen B, Wulf H
Br J Dermatol
. 2016 Feb;
174(5):979-84.
PMID: 26852899
Background: The main side-effects of photodynamic therapy (PDT) for actinic keratoses (AKs) are post-treatment erythema and oedema, and pain during illumination. Severe erythema after PDT enhances the down time associated...
5.
Wiegell S, Petersen B, Wulf H
Br J Dermatol
. 2014 Jul;
171(6):1487-92.
PMID: 25060803
Background: Photodynamic therapy (PDT) is an effective and established treatment for actinic keratoses (AK) and nonmelanoma skin cancer. The main side-effects of PDT are post-treatment erythema and oedema, and pain...
6.
Petersen B, Wiegell S, Wulf H
Br J Dermatol
. 2014 Feb;
171(1):175-8.
PMID: 24506809
Background: Photodynamic therapy (PDT) is followed by significant inflammation. Protoporphyrin (Pp)IX is still formed in the skin after PDT and patients are sensitive to daylight 24-48 h after treatment. Exposure...
7.
Wiegell S, Skodt V, Wulf H
J Eur Acad Dermatol Venereol
. 2013 Jan;
28(2):169-75.
PMID: 23294223
Background: Studies have shown that daylight-photodynamic therapy (PDT) is an effective treatment of actinic keratoses, nearly pain free and more convenient for both the clinics and patients. Treatment of basal...
8.
Wiegell S, Fabricius S, Heydenreich J, Enk C, Rosso S, Baumler W, et al.
Br J Dermatol
. 2012 Aug;
168(1):186-91.
PMID: 22860885
Background: Photodynamic therapy (PDT) is an attractive therapy for nonmelanoma skin cancers and actinic keratoses (AKs). Daylight-mediated methyl aminolaevulinate PDT (daylight-PDT) is a simple and painless treatment procedure for PDT....
9.
Wiegell S, Fabricius S, Gniadecka M, Stender I, Berne B, Kroon S, et al.
Br J Dermatol
. 2012 Jan;
166(6):1327-32.
PMID: 22250644
Background: Photodynamic therapy (PDT) is an attractive therapy for nonmelanoma skin cancers and actinic keratoses (AKs). Daylight-mediated PDT is a simple and tolerable treatment procedure for PDT. Methyl aminolaevulinate (MAL)-PDT...
10.
Wiegell S, Wulf H, Szeimies R, Basset-Seguin N, Bissonnette R, Gerritsen M, et al.
J Eur Acad Dermatol Venereol
. 2012 Jan;
26(6):673-9.
PMID: 22211665
Photodynamic therapy (PDT) is an attractive therapy for non-melanoma skin cancers including actinic keratoses (AKs) because it allows treatment of large areas; it has a high response rate and results...